Kindred Biosciences Inc

NASDAQ:KIN  
3.89
-0.11 (-2.75%)
Earnings Announcements

Kindred Biosciences Reports Q3 Loss Per Share Of $0.31

Published: 11/09/2020 22:42 GMT
Kindred Biosciences Inc (KIN) - Kindred Biosciences Announces Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.31.
Q3 Revenue $1.0 Million.
Q3 Revenue Estimate $563,000 -- Refinitiv Ibes Data (analyst estimates).
Q3 Earnings per Share Estimate $-0.30 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.86 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $5.26 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.